描述
Product Specifications
Attribute | Details |
---|---|
Product Name | Dutasteride Soft Capsules |
Generic Name | Dutasteride |
CAS Number | 164656?23?9 magistralbr.caldic.com+15en.wikipedia.org+15sciencedirect.com+15accessdata.fda.gov |
Molecular Formula | C??H??F?N?O? |
Molecular Weight | ~528.5?g/mol |
Dosage Form | Oral soft gelatin capsule |
Strength | 0.5?mg per capsule |
Pack Size | 10 capsules per box |
Approval No. | China NMPA H20234210 |
Product Code | 86901503000569 |
Manufacturer | Jiangsu Wangao Pharmaceutical Co., Ltd. |
Barcode | 6938033202990 |
Storage Conditions | Store at 2–8?°C or 15–25?°C; protect from light |
Intended Use | Laboratory/preclinical research only |
Mechanism of Action
Dutasteride is an irreversible inhibitor of both type I and II 5?-reductase enzymes, preventing conversion of testosterone to DHT. It reduces serum DHT levels by up to 98%, significantly more than finasteride (~65–70%) .
Research Applications & Pharmacology
-
Benign Prostatic Hyperplasia (BPH) Models: Widely used to study prostate volume reduction and LUTS in preclinical contexts .
-
Androgenetic Alopecia (AGA) Models: More effective than finasteride in hair growth studies, especially at 0.5?mg dosing .
-
Pharmacokinetics: Oral bioavailability ~60%, protein binding ~99%, metabolized via CYP3A4, elimination half-life ~4–5 weeks, mainly excreted in feces (~40%) .
-
Research Formulation Impact: Soft gelatin capsules offer higher bioavailability than tablets or hard capsules .
Safety Profile & Handling
-
Adverse Effects: Can cause sexual dysfunction, breast tenderness/gynecomastia (~1.3%), depression, and self-harm risks in long-term or high-dose models.
-
Drug Interactions/Contraindications: Avoid use in models with CYP3A4 inhibitors; contraindicated in female and pregnant subjects due to teratogenic risk .
-
Handling Instructions: Wear lab-safe PPE. Store per label instructions. Dispose of per institutional safety protocols.
评价
目前还没有评价